Skip to main content
. 2021 Jun 14;22:220. doi: 10.1186/s12882-021-02433-8

Fig. 2.

Fig. 2

The treatment course and changes in platelet count over time. The treatments involved steroid therapy with prednisolone (PSL), anticoagulant treatment during hemodialysis, intravenous cyclophosphamide (IVCY) therapy, and steroid pulse therapy with methylprednisolone (mPSL). The laboratory test parameters were changes in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) titers (red) and platelet counts (blue). The platelet counts improved after argatroban was started as anticoagulant treatment during hemodialysis